Compare AMPH & IART Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AMPH | IART |
|---|---|---|
| Founded | 1996 | 1989 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 971.8M | 823.8M |
| IPO Year | 2005 | 1996 |
| Metric | AMPH | IART |
|---|---|---|
| Price | $19.31 | $13.91 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 8 | 7 |
| Target Price | ★ $28.38 | $14.33 |
| AVG Volume (30 Days) | 371.8K | ★ 954.1K |
| Earning Date | 05-07-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 0.14 | N/A |
| Revenue | ★ $719,887,000.00 | N/A |
| Revenue This Year | $6.90 | $4.39 |
| Revenue Next Year | $4.64 | $3.40 |
| P/E Ratio | $11.87 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $17.03 | $8.70 |
| 52 Week High | $31.26 | $16.42 |
| Indicator | AMPH | IART |
|---|---|---|
| Relative Strength Index (RSI) | 36.58 | 72.93 |
| Support Level | $18.92 | $12.90 |
| Resistance Level | $20.08 | $14.38 |
| Average True Range (ATR) | 0.80 | 0.71 |
| MACD | -0.03 | 0.37 |
| Stochastic Oscillator | 14.80 | 89.60 |
Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient (or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment: pharmaceutical products. Geographically, the business presence of the firm is seen in the United States, China, and France, of which the U.S. accounts for the majority of the revenue.
Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and Tissue technologies. Codman Specialty Surgical generates maximum revenue from its segmental operations. Integra serves Europe, Asia Pacific, and the rest of the world whilst it derives key revenue from domestic sales. The company operates in United States, Europe, Asia Pacific, and Rest of the World.